8 Results for "

SHP2_IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "SHP2_IN-1" in MCE Product Catalog:

Cat. No.: HY-145703
CAS No.: 2740582-16-3
Purity:  99.76%
Target:  

PROTACs SHP2

Research Areas:  

Cancer

SHP2-D26 isomer-1 is an isoform of SHP2-D26 (HY-145162). SHP2-D26 isomer-1 cannot degrade SHP2 at 3-1000 nM. SHP2-D26 is a PROTAC SHP2 degrader .
Cat. No.: HY-21336
CAS No.: 928038-44-2
Target:  

SHP2

Research Areas:  

Others

3-Azetidinemethanol hydrochloride, an intermediate, can be used in the synthesis of SHP2 inhibitor .
Cat. No.: HY-114460
CAS No.: 1801764-90-8
Target:  

SHP2 Phosphatase

Research Areas:  

Others

SHP2-IN-1 (compound 13) is an allergic inhibitor of SHP2 (PTPN11), with an IC50 of 3 nM.
Cat. No.: HY-112478
CAS No.: 329317-98-8
Purity:  99.90%
Target:  

Phosphatase SHP2

Research Areas:  

Cancer

PTP Inhibitor IV is a protein tyrosine phosphatase (PTP) inhibitor that competitively inhibits DUSP14 phosphatase activity with an 50 of 5.21 μM . PTP Inhibitor IV inhibits SHP-2, PTP1B, PTP-ε, PTP Meg-2, PTP-σ, PTP-β, and PTP-μ with 50s of 1.8 μM, 2.5 μM, 8.4 μM, 13 μM, 20 μM, 6.4 μM, and 6.7 μM, respectively .
Cat. No.: HY-120901
CAS No.: 1143579-78-5
Target:  

SHP2 SHP1

Research Areas:  

Cancer

II-B08 is a reversible and noncompetitive SHP2 inhibitor (IC50: 5.5 μM, 15.7, 14.3 μM for SHP2, SHP1, PTP1B). II-B08 can be used for cancer research .
Cat. No.: HY-152208
CAS No.: 2907659-86-1
Target:  

SHP1 SHP2

Research Areas:  

Cancer

BPDA2 is a highly selective and competitive active site SHP2 inhibitor with IC50s of 92.0 nM, 33.39 μM, 40.71 μM for SHP2, SHP1, SHP1B, respectively. DBDA2 downregulates mitogenic and cell survival signaling and RTK expression. BPDA2 suppresses SHP2 mediated signaling and breast cancer cell phenotypes .
Cat. No.: HY-151464
CAS No.: 2831230-38-5
Target:  

SHP2 Phosphatase HDAC

Research Areas:  

Inflammation/Immunology Cancer

SHP2/HDAC-IN-1 is a dual allosteric SHP2/HDAC inhibitor with IC50 values of 20.4 nM (SHP2) and 25.3 nM (HDAC1) respectively. SHP2/HDAC-IN-1 triggers efficient antitumor immunity by activating T cells, enhancing the antigen presentation function and promoting cytokine secretion. SHP2/HDAC-IN-1 can be used in the research of cancer immunoresearch .
Cat. No.: HY-181239
CAS No.: 77500-30-2
Target:  

Phosphatase

Research Areas:  

Inflammation/Immunology Cancer

PTP1B-IN-33 is a PTP1B inhibitor with a human IC50 of 2.45 μM and over 20-fold selectivity for PTP1B over SHP2. PTP1B-IN-33 enhances π-Alkyl interaction with PTP1B to increase WPD loop closure degree. PTP1B-IN-33 can be used for the research of cancer, diabetes, autoimmune deficiency diseases .